#2207 CD3(+) T cell depletion does not predict short term outcomes in kidney transplant patients
Sign Up to like & getrecommendations! Published in 2024 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfae069.1003
Abstract: Anti-thymocyte globulin (ATG) is the most frequently agent used for immunosuppression induction therapy after kidney transplantation. The efficacy of the ATG treatment is monitored by peripheral blood CD3(+) T cell counts. ATG dosing can be… read more here.
Keywords: kidney transplant; cell; cd3 cell; cell counts ... See more keywords
How to Collect the Minimum-Targeted CD3+ Cells for CAR-T Therapy- the Bern Approach
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126534
Abstract: Introduction: An autologous CD3+ cell collection is the first step required for a CAR-T therapy. Up to now, in the commercial setting, one of the available models predicting the time or processed patient blood volume… read more here.
Keywords: cd3; blood; cd3 cell; apheresis ... See more keywords
Circulating CD4+ Treg, CD8+ Treg, and CD3+ γδ T Cell Subpopulations in Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2023 at "Medicina"
DOI: 10.3390/medicina59020205
Abstract: Background and Objectives: Regulatory T cells (Tregs) are usually enriched in ovarian cancer (OC), and their immunosuppressive function plays a key role in tumorigenesis and progression. We mainly explored the phenotypical characterization of Treg-related markers… read more here.
Keywords: cd3; treg; ovarian cancer; circulating cd4 ... See more keywords